Outbreak of Purpureocillium lilacinum fungal skin infections reported at Washington dermatology clinic

An outbreak report describes Purpureocillium lilacinum fungal skin infections occurring among patients at a dermatology clinic in Washington. The report does not specify the number of patients affected, the specific interventions or exposures involved, or the comparator groups studied. No primary or secondary outcomes, effect sizes, absolute numbers, or statistical measures are reported.

Safety and tolerability information is not reported, including adverse events, serious adverse events, or discontinuations. The report does not mention funding sources or potential conflicts of interest.

Key limitations include the absence of detailed epidemiological data, clinical outcomes, and investigation into the source or mode of transmission. The practice relevance is not specified, but the report highlights the occurrence of this fungal infection in a clinical setting. This serves as a descriptive alert rather than providing evidence for clinical decision-making.